OA10261A - New paroxetine derivatives - Google Patents

New paroxetine derivatives Download PDF

Info

Publication number
OA10261A
OA10261A OA60773A OA60773A OA10261A OA 10261 A OA10261 A OA 10261A OA 60773 A OA60773 A OA 60773A OA 60773 A OA60773 A OA 60773A OA 10261 A OA10261 A OA 10261A
Authority
OA
OAPI
Prior art keywords
paroxetine hydrochloride
paroxetine
solvaté
anhydrate
propan
Prior art date
Application number
OA60773A
Other languages
English (en)
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA10261(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en
Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en
Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA10261A publication Critical patent/OA10261A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA60773A 1995-02-06 1996-02-06 New paroxetine derivatives OA10261A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GBGB9503112.6A GB9503112D0 (en) 1995-02-17 1995-02-17 Novel compound
GBGB9509807.5A GB9509807D0 (en) 1995-05-15 1995-05-15 Novel compounds

Publications (1)

Publication Number Publication Date
OA10261A true OA10261A (en) 1997-09-19

Family

ID=27267578

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60773A OA10261A (en) 1995-02-06 1996-02-06 New paroxetine derivatives

Country Status (47)

Country Link
EP (3) EP1378508A1 (ro)
JP (2) JP2915338B2 (ro)
KR (1) KR100289885B1 (ro)
CN (3) CN1090187C (ro)
AR (2) AR001982A1 (ro)
AT (1) AT407528B (ro)
AU (2) AU4786496A (ro)
BE (1) BE1009112A3 (ro)
BG (1) BG62967B1 (ro)
BR (1) BR9600534A (ro)
CA (2) CA2211522C (ro)
CH (3) CH688353A5 (ro)
CZ (1) CZ297171B6 (ro)
DE (3) DE69631298T2 (ro)
DK (2) DK11996A (ro)
DZ (1) DZ1989A1 (ro)
ES (1) ES2114471B1 (ro)
FI (3) FI111544B (ro)
FR (1) FR2730232B1 (ro)
GR (1) GR1002466B (ro)
HK (1) HK59397A (ro)
HU (1) HUP9600255A1 (ro)
IE (1) IE80500B1 (ro)
IL (1) IL117035A (ro)
IT (1) IT1289532B1 (ro)
LU (1) LU88711A1 (ro)
LV (1) LV11618B (ro)
MA (1) MA23802A1 (ro)
MC (1) MC2411A1 (ro)
MX (1) MX9600484A (ro)
MY (1) MY132529A (ro)
NL (1) NL1002248C2 (ro)
NO (3) NO301009B1 (ro)
NZ (1) NZ280943A (ro)
OA (1) OA10261A (ro)
PL (1) PL189247B1 (ro)
PT (1) PT101827B (ro)
RO (1) RO112426B1 (ro)
RU (1) RU2125052C1 (ro)
SE (1) SE521084C2 (ro)
SG (1) SG43787A1 (ro)
SI (2) SI9600036B (ro)
SK (1) SK283608B6 (ro)
TR (1) TR199600096A2 (ro)
TW (1) TW503238B (ro)
UA (1) UA49796C2 (ro)
WO (1) WO1996024595A1 (ro)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1394160A1 (en) * 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Process for preparing crystalline paroxetin hydrochloride
WO1998002556A2 (en) * 1996-07-15 1998-01-22 Smithkline Beecham Plc Screening for and use of an esterase for a stereospecific resolution
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
IL133366A (en) * 1997-06-10 2005-11-20 Synthon Bv 4-Phenylpiperidine compounds, process for their preparation and uses thereof
DE59801792D1 (de) * 1997-08-08 2001-11-22 Aventis Pharma Gmbh Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
TR200002675T2 (tr) * 1998-03-16 2000-12-21 Smithkline Beecham Plc Paroksetinin kristalin formu.
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
AU2003200534B2 (en) * 1998-03-24 2004-12-02 Smithkline Beecham Plc Paroxetine compositions
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
DK1100796T3 (da) * 1998-08-07 2003-08-25 Smithkline Beecham Plc Fremgangsmåde til fremstilling af en ikke-krystallinsk anhydratform af paroxetinhydrochlorid
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826176D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
DK1135383T3 (da) * 1998-11-30 2004-04-05 Smithkline Beecham Plc Blandede paroxetin-propan-2-ol-solvater
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
IT1308629B1 (it) * 1999-02-23 2002-01-09 Recordati Chem Pharm Processo per la produzione di paroxetina.
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9914585D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
JPWO2002022609A1 (ja) * 2000-09-14 2004-01-22 旭硝子株式会社 実質的に有機溶媒を含まないパロキセチン塩類の製造方法
IL163593A0 (en) * 2002-02-22 2005-12-18 Teva Pharma Preparation of paroxetine involving novel intermediates
WO2007062147A1 (en) * 2005-11-22 2007-05-31 Teva Pharmaceutical Industries Ltd. Crystal forms of cinacalcet hci and processes for their preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
WO1992009281A2 (en) * 1990-11-24 1992-06-11 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
NO970939L (no) 1996-08-07
MA23802A1 (fr) 1996-10-01
MC2411A1 (fr) 1996-12-02
MX198371B (ro) 2000-08-29
LV11618B (en) 1997-04-20
LV11618A (lv) 1996-12-20
FI960519L (fi) 1996-08-07
SE9600406L (sv) 1996-08-07
FI111544B (fi) 2003-08-15
RU2125052C1 (ru) 1999-01-20
NO20015070D0 (no) 2001-10-18
DE69631298D1 (de) 2004-02-12
CA2168829C (en) 1997-12-16
SI21923A (sl) 2006-06-30
CZ32096A3 (en) 1996-08-14
CA2210023C (en) 1999-02-09
DE69621777D1 (de) 2002-07-18
CA2210022C (en) 2005-09-13
BG100333A (bg) 1996-08-30
FI20030370A7 (fi) 2003-03-12
LU88711A1 (fr) 1996-08-23
DE19603797C2 (de) 1998-11-12
DE69621777T2 (de) 2003-01-02
DE69631298T2 (de) 2004-11-18
PT101827A (pt) 1996-09-30
CA2211522A1 (en) 1996-08-07
AU701518B2 (en) 1999-01-28
CN1143643A (zh) 1997-02-26
FI960519A0 (fi) 1996-02-05
SG43787A1 (en) 1997-11-14
CH688353A5 (de) 1997-08-15
CH689229A5 (de) 1998-12-31
SI9600036B (sl) 2006-12-31
CN1636993A (zh) 2005-07-13
JPH08245620A (ja) 1996-09-24
HU9600255D0 (en) 1996-03-28
ES2114471A1 (es) 1998-05-16
ITMI960203A1 (it) 1997-08-05
RO112426B1 (ro) 1997-09-30
CZ297171B6 (cs) 2006-09-13
ES2114471B1 (es) 1999-08-16
DK11996A (da) 1996-08-07
DZ1989A1 (fr) 2002-10-15
ATA21096A (de) 2000-08-15
TR199600096A2 (tr) 1996-08-21
DE19603797A1 (de) 1996-08-14
FR2730232A1 (fr) 1996-08-09
DK200100223A (ro) 2001-02-12
FI20030162A7 (fi) 2003-02-03
NO960472L (no) 1996-08-07
TW503238B (en) 2002-09-21
CA2210023A1 (en) 1996-08-07
KR100289885B1 (ko) 2001-05-15
EP1136490B1 (en) 2004-01-07
IL117035A (en) 2000-02-29
AR036856A2 (es) 2004-10-06
CH689804A5 (de) 1999-11-30
EP0808314A1 (en) 1997-11-26
AU701518C (en) 2006-12-07
NO20015070L (no) 1996-08-07
BG62967B1 (bg) 2000-12-29
JPH11228571A (ja) 1999-08-24
CA2168829A1 (en) 1996-08-07
AU4332896A (en) 1996-08-15
CN1216055C (zh) 2005-08-24
NO970939D0 (no) 1997-02-28
IL117035A0 (en) 1996-09-12
IT1289532B1 (it) 1998-10-15
CN1310180A (zh) 2001-08-29
NZ280943A (en) 1997-01-29
CA2211522C (en) 1999-12-07
FR2730232B1 (fr) 1997-08-01
NO960472D0 (no) 1996-02-05
NO301009B1 (no) 1997-09-01
CN1090187C (zh) 2002-09-04
AR001982A1 (es) 1998-01-07
KR960031409A (ko) 1996-09-17
MX9600484A (es) 1997-01-31
FI20030370L (fi) 2003-03-12
AU4786496A (en) 1996-08-27
CN1289496C (zh) 2006-12-13
AT407528B (de) 2001-04-25
GR1002466B (el) 1996-11-06
PT101827B (pt) 1997-08-29
NL1002248A1 (nl) 1996-08-06
IE960104A1 (en) 1996-08-07
ITMI960203A0 (ro) 1996-02-05
EP0808314B1 (en) 2002-06-12
BE1009112A3 (fr) 1996-11-05
WO1996024595A1 (en) 1996-08-15
BR9600534A (pt) 1997-05-13
CA2210022A1 (en) 1996-08-07
EP1136490A1 (en) 2001-09-26
PL189247B1 (pl) 2005-07-29
SK283608B6 (sk) 2003-10-07
MY132529A (en) 2007-10-31
EP1378508A1 (en) 2004-01-07
NO301009B3 (ro) 2003-01-06
NO311519B1 (no) 2001-12-03
SK14396A3 (en) 1996-11-06
SI21923B (sl) 2006-12-31
SI9600036A (en) 1996-10-31
IE80500B1 (en) 1998-08-12
SE9600406D0 (sv) 1996-02-05
JP2915338B2 (ja) 1999-07-05
HK59397A (en) 1997-05-16
PL312646A1 (en) 1996-08-19
HUP9600255A1 (en) 1997-03-28
SE521084C2 (sv) 2003-09-30
UA49796C2 (uk) 2002-10-15
NL1002248C2 (nl) 1996-09-11
FI20030162L (fi) 2003-02-03

Similar Documents

Publication Publication Date Title
OA10261A (en) New paroxetine derivatives
US6133289A (en) Paroxetine hydrochloride form A or C
CY2015A (en) Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
CA2210023E (en) Process for the preparation of paroxetine hydrochloride anhydrate form a.
AU740561B2 (en) Paroxetine hydrochloride anhydrate
CA2211521A1 (en) Novel paroxetine hydrochlorine anhydrate forms
CA2168829E (en) Paroxetine hydrochloride anhydrate forms a,b,c and d
LT4100B (en) Paroxetine hydrochloride anhydrate and process for preparing thereof